Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Mauritius.
Press releases published on September 11, 2025
Chilldyne and Carahsoft Partner to Deliver Risk-Free Liquid Cooling to Government Agencies Nationwide
CARLSBAD, Calif., and RESTON, Va., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Chilldyne, Inc., a leader in negative pressure liquid cooling technology, and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, today announced a partnership. …
Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
NPI-001 shows more than 50% reduction in photoreceptor loss caused by RP associated with USH over two years NPI-001 was well tolerated, with no persistent drug-related adverse events Results were leveraged to design confirmatory trial planned for 2026 FORT …
New Engen Earns Spot on ADWEEK’s Fastest Growing Agencies List for Third Consecutive Year, Ranking Among Top Five Large Agencies in 2025
SEATTLE, Sept. 11, 2025 (GLOBE NEWSWIRE) -- New Engen, a leading digital marketing agency, today announced its recognition on the 2025 ADWEEK Fastest Growing Agencies list for the third consecutive year, ranking among the top five large agencies this year. …
Longer-Term Forecasts for Litecoin are More Optimistic with Bullish Expectations Suggested
PALM BEACH, Fla., Sept. 11, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Numerous crypto news industry insiders are bullish for Litecoin this year and through 2031. One such observer said: “The crypto market is entering a new chapter where …
LIS Technologies Inc. Appoints Former Air Force Lead for Strategy, Integration, and Requirements, Lieutenant General Hinote (Ret.) as its Executive Chair of Federal and Defense Initiatives
Oak Ridge, Tennessee, Sept. 11, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that …
AgEagle Aerial Systems Rebrands as EagleNXT to Drive Next Phase of Growth and Innovation
Rebrand reflects strategic evolution and positions EagleNXT to capture global expansion opportunities across defense, agriculture, and commercial drone markets WICHITA, Kan., Sept. 11, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a …
isolved Among Select Platinum Partners Integrated with Indeed’s New Talent Scout Solution
CHARLOTTE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- isolved®, a provider of human capital management (HCM) solutions that help organizations recruit, retain and elevate their workforce, today announced it is one of only two hand-selected partners worldwide …
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available treatments for IPF are limited to only two approved drugs …
Shoals Technologies Group Secures a New Patent for BLA Architecture, Reinforcing American Intellectual Property
PORTLAND, Tenn., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Shoals) (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced today the issuance of its new U.S. …
VERSES® Expands Commercial Relationship with Major Global Investment Firm
VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation agentic software systems, today announced an additional …
FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment
HOUSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
MORRISVILLE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present four …
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th
MOUNTAIN VIEW, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug- …
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring
Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-driven clinical workflows BERKELEY, Calif, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: …
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP) Breadth of the data across Phase 2 program to be discussed at Arrowhead’s 19th Annual Pain Summit THE …
Intercept Announces Voluntary Withdrawal of OCALIVA® for Primary Biliary Cholangitis (PBC) from the US Market; US Clinical Trials Involving Obeticholic Acid Placed on Clinical Hold
MORRISTOWN, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today announced its decision to voluntarily withdraw OCALIVA® (obeticholic acid) from the US market for …
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
FLORHAM PARK, N.J. and GARCHING, Germany and MUNICH, Germany, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB, “Cellectar”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for …